Gregor Novak
3PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 08, 2025
High persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study.Živa Šubic, David Drobne, Gregor Novak
|Feb 24, 2024
Remission Is Maintained after Switch from Dose-Optimised Intravenous Treatment to Subcutaneous Treatment with Vedolizumab in Inflammatory Bowel Disease.Špela Pintar, Jurij Hanžel, David Drobne
|Oct 23, 2021
Ustekinumab Dosing Individualization in Crohn's Disease Guided by a Population Pharmacokinetic-Pharmacodynamic Model.Jurij Aguiar Zdovc, Jurij Hanžel, Tina Kurent
Pageof 1
